Friday's top analyst upgrades and downgrades included Arista Networks, DataDog, FedEx, Fiserv, Gilead Sciences, Global Payments, Nvidia, Oatly, Pfizer, Target, TJX Companies and Victoria’s Secret.
One of Cathie Wood's ARK Invest exchange-traded funds sold over 400,000 shares of Pfizer on November 11.
One of Cathie Wood's ARK Invest exchange-traded funds sold over 140,000 shares of Pfizer on November 10.
One of Cathie Wood's ARK Invest exchange-traded funds sold over 230,000 shares of Pfizer on November 9.
An oil and gas supermajor looking to transform its business, a Dow component and a struggling athletic gear company are reporting earnings before markets open Tuesday.
One of Cathie Wood's ARK Invest exchange-traded funds bought over 180,000 shares of Pfizer on September 7.
One of Cathie Wood's ARK Invest exchange-traded funds bought over 380,000 shares of Pfizer on September 1.
One of Cathie Wood's ARK Invest exchange-traded funds bought over 350,000 shares of Pfizer on August 27.
One of Cathie Wood's ARK Invest exchange-traded funds bought over 170,000 shares of Pfizer on August 26.
One of Cathie Wood's ARK Invest exchange-traded funds bought over 160,000 shares of Pfizer on August 23.
One of Cathie Wood's ARK Invest funds bought over 150,000 shares of Pfizer on August 18.
Tuesday's top analyst upgrades and downgrades included AbbVie, Alibaba, American Airlines, AT&T, Chipotle Mexican Grill, JD.com, Kimberly-Clark, Pfizer, Starbucks and Weyerhaeuser.
Two Dow Jones industrial average components report quarterly earnings before markets open Wednesday, along with a cannabis company that gets some attention as a meme stock.
Thursday's top analysts upgrades and downgrades included Apple, Darden Restaurants, Peloton, Pfizer, Pioneer Natural Resources, Tilray and Zynga.
Two alternative energy companies report March quarter earnings after the closing bell Monday, and three other noteworthy reports are due before Tuesday's opening bell.
